• PGPC Drives Endothelial Ferroptosis via FABP3: Vascular Impa

  2026-05-27

  This study demonstrates that the oxidized phospholipid PGPC impairs endothelial function by inducing ferroptosis through the CD36-FABP3 pathway. The findings clarify a mechanistic link between lipid oxidation, ferroptotic cell death, and vascular dysfunction, suggesting new therapeutic targets for atherosclerosis.

• Quercetin Suppresses NLRP3 Inflammasome in LPS-Induced Depre

  2026-05-26

  This study uncovers quercetin's neuroprotective and antidepressant-like effects in a mouse model of LPS-induced depression by inhibiting NLRP3 inflammasome activation and reducing neuroinflammatory cytokines. The findings support quercetin's mechanistic value for research into depression and cognitive dysfunction.

• S-Adenosylmethionine (SAM): Advanced Insights for Epigenetic

  2026-05-26

  Explore the multifaceted roles of S-adenosylmethionine (Ademetionine) in methylation reactions and neuropsychiatric research. This article delivers new depth on assay design, protocol optimization, and translational relevance, setting it apart from standard guides.

• Dissecting In Vitro Metrics for Anticancer Drug Response Ana

  2026-05-25

  Schwartz's dissertation clarifies the distinct cellular effects measured by relative and fractional viability assays in cancer drug research. By separating proliferative arrest from cell death, the work advances the precision of in vitro drug evaluation and informs experimental design for antitumor agents, including topoisomerase 1 inhibitors.

• Iron Stress Alters Enterocyte Metabolism and Inflammation

  2026-05-25

  Navazesh and Ji (2025) demonstrate that both iron deficiency and excess profoundly reprogram enterocyte metabolism and inflammatory gene expression in IPEC-J2 cells. Their work clarifies the metabolic and transcriptional consequences of iron imbalance in intestinal epithelial biology, informing experimental models and therapeutic strategies around iron modulation.

• Dicoumarol Inhibits IRE1α to Mitigate ER Stress-Induced Live

  2026-05-24

  A recent study developed a high-throughput strategy combining molecular docking and reporter-based screening to identify dicoumarol as a potent inhibitor of IRE1α, a key unfolded protein response mediator. The findings demonstrate dicoumarol's effectiveness in protecting hepatocytes from ER stress-induced injury, establishing a new framework for therapeutic discovery in liver disease.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-05-23

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide a robust and efficient solution for isolating or purifying biotinylated molecules from complex biological samples, with minimized nonspecific binding. These beads are best suited for workflows requiring rapid, high-specificity capture—such as immunoprecipitation, protein interaction studies, and nucleic acid purification—while applications outside the biotin-streptavidin system or requiring direct mechanistic evidence should be approached with caution.

• Benzyl-Activated Streptavidin Magnetic Beads: Enabling Advan

  2026-05-22

  Explore the unique advantages of Benzyl-activated Streptavidin Magnetic Beads for sensitive biotinylated molecule capture, with deep insight into their role in emerging viral entry research. This article goes beyond standard protocols, revealing advanced applications and mechanistic details.

• Y-27632: ROCK Inhibitor Protocols for Cytoskeletal Modulatio

  2026-05-22

  Y-27632, a selective ROCK inhibitor from APExBIO, empowers researchers to dissect cytoskeletal dynamics and stress fiber regulation in advanced cell models. This article translates leading-edge experimental workflows and troubleshooting strategies into actionable guidance for cancer biology and regenerative research.

• D-Lin-MC3-DMA: Precision Lipid for Next-Gen mRNA Delivery

  2026-05-21

  Explore D-Lin-MC3-DMA as an advanced ionizable cationic liposome for mRNA and siRNA delivery. This article reveals new insights into machine learning-guided LNP design and practical protocol choices that set it apart from existing overviews.

• Iron Stress Alters Enterocyte Metabolism and Inflammatory Si

  2026-05-21

  Navazesh and Ji's 2025 study reveals how both iron deficiency and excess profoundly reshape enterocyte metabolic and inflammatory pathways. Using IPEC-J2 cell models and untargeted metabolomics, the research maps iron-dependent transcriptional, metabolic, and immune effects, informing experimental approaches to intestinal iron homeostasis.

• Fucoidan (C4038): Mechanistic Precision for Cancer and Antiv

  2026-05-20

  Discover how Fucoidan, a sulfated α-L-Fucan, drives precise apoptosis induction and immune modulation in cancer and antiviral models. This deep-dive uniquely analyzes cross-domain mechanisms and the practical impact of recent nuclear egress research.

• hiPSC-Derived Sensory Neurons Model HSV-1 Latency and Reacti

  2026-05-20

  This study establishes a robust system for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons, enabling detailed modeling of herpes simplex virus 1 (HSV-1) latent infection and reactivation. The platform overcomes previous limitations of scalability and human relevance, offering new opportunities to investigate neuron-intrinsic mechanisms of HSV-1 latency and potential therapeutic strategies.

• Capsazepine: Precision TRPV1 Antagonist for Pain and Cancer

  2026-05-19

  Explore how Capsazepine, a leading TRPV1 ion channel antagonist, enables advanced interrogation of pain signaling and apoptosis sensitization in cancer cells. This article provides a unique, cross-functional analysis of Capsazepine’s applications, mechanisms, and protocols—bridging translational pain research with oncology insights.

• Resveratrol Suppresses CAF-Driven Growth in Breast Cancer Or

  2026-05-19

  This study demonstrates that resveratrol inhibits both growth and VCAN expression in breast cancer organoids co-cultured with cancer-associated fibroblasts (CAFs), using advanced organoid models and proliferation assays. The findings highlight the importance of simulating the tumor microenvironment for evaluating drug efficacy and suggest that targeting CAF-mediated pathways may overcome resistance in breast cancer.

389 records 6/26 page Previous Next First page 上5页 678910 下5页 Last page